论文部分内容阅读
我院从1994年到1995年12月,用PCMF和CAF联合化疗方案治疗晚期乳腺癌48例,效果满意。PCMF方案的有效率为66.7%(16/24),其中CR为29.2%(7/24),PR为37.5%(9/24)。CAF方案的有效率为58.3%(14/24),其中CR为20.8%(5/24),PR为37.5%(9/24)。两种方案疗效无显著差别(P>0.05)。中位缓解期分别为7和8个月,两种方案相近。
In our hospital from 1994 to December 1995, 48 patients with advanced breast cancer were treated with the PCMF and CAF combined chemotherapy regimens with satisfactory results. The effective rate of the PCMF program was 66.7% (16/24), of which CR was 29.2% (7/24) and PR was 37.5% (9/24). The effective rate of the CAF program was 58.3% (14/24), of which CR was 20.8% (5/24) and PR was 37.5% (9/24). There was no significant difference in efficacy between the two regimens (P>0.05). The median remission period was 7 and 8 months respectively, and the two schemes were similar.